In healthcare environments handling hazardous drugs, safety is not only a clinical concern but also a matter of occupational health, environmental protection and regulatory compliance. Cytotoxic and biologic agents used in oncology and chemotherapy require advanced protection systems to reduce exposure risks.
Closed System Drug Transfer Devices (CSTD) are mechanically engineered systems designed to prevent the escape of hazardous drugs in the form of aerosols, vapors or droplets during preparation, transfer and administration. At the same time, they prevent external contaminants from entering the system, providing dual protection.
Traditional open systems may generate microscopic leaks during drug compounding and transfer. This can lead to:
Organizations such as NIOSH and USP <800> recommend the use of closed systems when handling hazardous drugs.
Benefits of CSTD Technology
✔ Minimizes aerosol and droplet formation
✔ Reduces leakage risk
✔ Prevents environmental contamination
✔ Standardizes clinical workflows
✔ Supports compliance with international safety standards
In modern hospitals, CSTD implementation is no longer optional—it is becoming a safety benchmark.
Engineering-driven solutions such as AEGISELL integrate drug safety seamlessly into clinical practice, enhancing both protection and operational efficiency.
